A standardized extract of Opuntia ficus‐indica (L.) Mill and Olea europaea L. improves gastrointestinal discomfort: A double‐blinded randomized‐controlled study

Gastrointestinal discomfort (GD), which often includes gastroesophageal reflux disease (GERD), is a common disorder in healthy adults affecting 40% of the worldwide population. The symptoms related to GD can have a negative impact on the quality of life (QoL). Current treatments for GERD are associated with side effects. We conducted a randomized double‐blind placebo‐controlled trial to assess the effect of a standardized extract of Opuntia ficus‐indica L. cladodes and Olea europaea L. leaves on the symptoms and QoL of healthy adults with GD. One hundred healthy participants with GD were enrolled in the study and divided into two groups: 60 participants taking verum (400 mg/day) and 40 taking the placebo for 8 weeks. The Gastrointestinal Quality of Life index (GIQLI) and GERD Symptom Assessment Scale (GSAS) questionnaires were administered at the beginning of the study and after 4 and 8 weeks. The group treated with verum experienced a statistically significant improvement of GIQLI and GSAS scores (p < .001). Moreover, the effect size measured revealed a clinical significance. A day‐dependent improvement of symptoms was also observed. The standardized extract represents a fast, effective, and well‐tolerated treatment for improving symptoms related to GD and GERD.

[1]  I. Es-safi,et al.  Medicinal plants used to treat acute digestive system problems in the region of Fez-Meknes in Morocco: An ethnopharmacological survey , 2020 .

[2]  Taraneh Mousavi,et al.  Drug discovery strategies for modulating oxidative stress in gastrointestinal disorders , 2020, Expert opinion on drug discovery.

[3]  Heekuk Park,et al.  Sex-Specific Differences in the Gut Microbiome in Response to Dietary Fiber Supplementation in IL-10-Deficient Mice , 2020, Nutrients.

[4]  A. Feizi,et al.  Combined Healthy Lifestyle Is Inversely Associated with Upper Gastrointestinal Disorders among Iranian Adults , 2020, Digestive Diseases.

[5]  P. Whorwell,et al.  Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. , 2020, Gastroenterology.

[6]  D. Ağagündüz,et al.  Olive Leaf (Olea europaea L. folium): Potential Effects on Glycemia and Lipidemia , 2020, Annals of Nutrition and Metabolism.

[7]  R. Bauer,et al.  The role of gut microbiota for the activity of medicinal plants traditionally used in the European Union for gastrointestinal disorders. , 2019, Journal of ethnopharmacology.

[8]  A. Romani,et al.  Health Effects of Phenolic Compounds Found in Extra-Virgin Olive Oil, By-Products, and Leaf of Olea europaea L. , 2019, Nutrients.

[9]  Chia-Chi Wang,et al.  The role of tea and coffee in the development of gastroesophageal reflux disease , 2019, Ci ji yi xue za zhi = Tzu-chi medical journal.

[10]  K. Haruma,et al.  Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study , 2019, Journal of Gastroenterology.

[11]  C. Faggio,et al.  Opuntia ficus-indica (L.) Miller as a source of bioactivity compounds for health and nutrition , 2018, Natural product research.

[12]  Gang Zhu,et al.  Gut–Brain Axis and Mood Disorder , 2018, Front. Psychiatry.

[13]  A. Hichami,et al.  Protective effects of polyphenol-rich infusions from carob (Ceratonia siliqua) leaves and cladodes of Opuntia ficus-indica against inflammation associated with diet-induced obesity and DSS-induced colitis in Swiss mice. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[14]  R. Lanzetta,et al.  The polysaccharide and low molecular weight components of Opuntia ficus indica cladodes: Structure and skin repairing properties. , 2017, Carbohydrate polymers.

[15]  Jian-zhong Ye,et al.  Enzymatic Hydrolysis of Oleuropein from Olea europea (Olive) Leaf Extract and Antioxidant Activities , 2015, Molecules.

[16]  Nayoung Kim,et al.  Abdominal Bloating: Pathophysiology and Treatment , 2013, Journal of neurogastroenterology and motility.

[17]  V. Cardile,et al.  Caco-2 cell line as a model to evaluate mucoprotective proprieties. , 2012, International journal of pharmaceutics.

[18]  H. El‐Serag,et al.  Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies , 2010, Alimentary pharmacology & therapeutics.

[19]  R. Fass.  Symptom Assessment Tools for Gastroesophageal Reflux Disease (GERD) Treatment , 2007, Journal of clinical gastroenterology.

[20]  C. Puglia,et al.  Effect of polysaccharides from Opuntia ficus-indica (L.) cladodes on the healing of dermal wounds in the rat. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[21]  D. Giuffrida,et al.  Chemical characterization and biological effects of Sicilian Opuntia ficus indica (L.) mill. Fruit juice: antioxidant and antiulcerogenic activity. , 2003, Journal of agricultural and food chemistry.

[22]  M. M. Tripodo,et al.  Study on the increment of the production of gastric mucus in rats treated with Opuntia ficus indica (L.) Mill. cladodes. , 2002, Journal of ethnopharmacology.

[23]  A. Damiano,et al.  Measuring Symptom Distress and Health-Related Quality of Life in Clinical Trials of Gastroesophageal Reflux Disease Treatment: Further Validation of the Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS) , 2002, Digestive Diseases and Sciences.

[24]  M. M. Tripodo,et al.  Antiulcer activity of Opuntia ficus indica (L.) Mill. (Cactaceae): ultrastructural study. , 2001, Journal of ethnopharmacology.

[25]  E. Irvine,et al.  Quality of life measurement in gastrointestinal and liver disorders , 2000, Gut.

[26]  J. Williams,et al.  [The Gastrointestinal Quality of Life Index. A clinical index for measuring patient status in gastroenterologic surgery]. , 1993, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[27]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[28]  C. Caggia,et al.  GUT MICROBIOTA, PROBIOTICS AND COLORECTAL CANCER: A TIGHT RELATION , 2020 .

[29]  M. Schmulson,et al.  Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico. , 2019, Revista de gastroenterologia de Mexico.

[30]  Y. Eren,et al.  Aqueous Extracts , 2017 .

[31]  N. Radonjić,et al.  Attenuation of cold restraint stress-induced gastric lesions by an olive leaf extract. , 2009, General physiology and biophysics.

[32]  I. Wiklund,et al.  Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease , 2004, Quality of Life Research.